17-44883641-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004247.4(EFTUD2):​c.426+8G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.596 in 1,610,642 control chromosomes in the GnomAD database, including 289,269 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.61 ( 29385 hom., cov: 32)
Exomes 𝑓: 0.59 ( 259884 hom. )

Consequence

EFTUD2
NM_004247.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00008388
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.555

Publications

25 publications found
Variant links:
Genes affected
EFTUD2 (HGNC:30858): (elongation factor Tu GTP binding domain containing 2) This gene encodes a GTPase which is a component of the spliceosome complex which processes precursor mRNAs to produce mature mRNAs. Mutations in this gene are associated with mandibulofacial dysostosis with microcephaly. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
EFTUD2 Gene-Disease associations (from GenCC):
  • mandibulofacial dysostosis-microcephaly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 17-44883641-C-T is Benign according to our data. Variant chr17-44883641-C-T is described in ClinVar as Benign. ClinVar VariationId is 128972.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.725 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EFTUD2NM_004247.4 linkc.426+8G>A splice_region_variant, intron_variant Intron 5 of 27 ENST00000426333.7 NP_004238.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EFTUD2ENST00000426333.7 linkc.426+8G>A splice_region_variant, intron_variant Intron 5 of 27 1 NM_004247.4 ENSP00000392094.1

Frequencies

GnomAD3 genomes
AF:
0.614
AC:
93373
AN:
151964
Hom.:
29358
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.732
Gnomad AMI
AF:
0.640
Gnomad AMR
AF:
0.471
Gnomad ASJ
AF:
0.627
Gnomad EAS
AF:
0.489
Gnomad SAS
AF:
0.496
Gnomad FIN
AF:
0.557
Gnomad MID
AF:
0.595
Gnomad NFE
AF:
0.602
Gnomad OTH
AF:
0.596
GnomAD2 exomes
AF:
0.561
AC:
141071
AN:
251344
AF XY:
0.561
show subpopulations
Gnomad AFR exome
AF:
0.730
Gnomad AMR exome
AF:
0.409
Gnomad ASJ exome
AF:
0.615
Gnomad EAS exome
AF:
0.496
Gnomad FIN exome
AF:
0.560
Gnomad NFE exome
AF:
0.602
Gnomad OTH exome
AF:
0.570
GnomAD4 exome
AF:
0.594
AC:
866578
AN:
1458558
Hom.:
259884
Cov.:
33
AF XY:
0.592
AC XY:
429398
AN XY:
725742
show subpopulations
African (AFR)
AF:
0.732
AC:
24452
AN:
33408
American (AMR)
AF:
0.419
AC:
18752
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.617
AC:
16113
AN:
26104
East Asian (EAS)
AF:
0.478
AC:
18987
AN:
39690
South Asian (SAS)
AF:
0.515
AC:
44376
AN:
86176
European-Finnish (FIN)
AF:
0.557
AC:
29759
AN:
53416
Middle Eastern (MID)
AF:
0.610
AC:
3513
AN:
5762
European-Non Finnish (NFE)
AF:
0.609
AC:
675203
AN:
1109022
Other (OTH)
AF:
0.588
AC:
35423
AN:
60266
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
15870
31740
47611
63481
79351
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18216
36432
54648
72864
91080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.614
AC:
93441
AN:
152084
Hom.:
29385
Cov.:
32
AF XY:
0.604
AC XY:
44906
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.732
AC:
30365
AN:
41478
American (AMR)
AF:
0.472
AC:
7202
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.627
AC:
2175
AN:
3470
East Asian (EAS)
AF:
0.488
AC:
2517
AN:
5156
South Asian (SAS)
AF:
0.495
AC:
2392
AN:
4828
European-Finnish (FIN)
AF:
0.557
AC:
5892
AN:
10580
Middle Eastern (MID)
AF:
0.602
AC:
177
AN:
294
European-Non Finnish (NFE)
AF:
0.602
AC:
40893
AN:
67984
Other (OTH)
AF:
0.590
AC:
1247
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1859
3719
5578
7438
9297
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
766
1532
2298
3064
3830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.601
Hom.:
53115
Bravo
AF:
0.615
Asia WGS
AF:
0.474
AC:
1649
AN:
3478
EpiCase
AF:
0.595
EpiControl
AF:
0.591

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mandibulofacial dysostosis-microcephaly syndrome Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
4.8
DANN
Benign
0.74
PhyloP100
-0.56
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000084
dbscSNV1_RF
Benign
0.012
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2289677; hg19: chr17-42961009; COSMIC: COSV68182194; COSMIC: COSV68182194; API